hepatitis C

HCV patients at risk of nonadherence using Proteus' digital pill achieve sustained viral clearance

By Dave Muoio 04:09 pm November 14, 2019

A new study suggests that Proteus Digital Health’s sensor-embedded pills can improve adherence among Hepatitis C (HCV) patients who are at a high risk for nonadherence. The data — presented this week at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting — indicate a 93% overall rate of medication adherence, and a 99.5% rate of sustained virologic response recorded...

PharMedQuest invests in helparound, will co-market HIV, Hepatitis C management platform

By Laura Lovett 02:55 pm December 20, 2017

Correction: A previous version of this article misstated that ACE was the name of the mobile app. ACE is the name of PharMedQuest's customer relationship management platform and not the mobile app. Healthcare management company PharMedQuest announced last week that it has made a strategic investment in helparound, an Israeli company which makes an app that supports and connects patients with...